je.st
news
Merck 3Q net income falls on charges, lower sales
2013-10-28 16:30:31| Biotech - Topix.net
Merck & Co. said Monday that its third-quarter profit plunged 35 percent because of competition from generic drugs, lower sales of its top-selling medicine, and restructuring and acquisition charges.
Tags: net
sales
lower
income
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||